Decline and rise of the antimicrobial susceptibility of Streptococcus pneumoniae isolated from middle ear fluid in children: Influence of changes in circulating serotypes

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 7, 2012, Pages 3989-3991

  Pérez Trallero, Emilio ^a,b,c   Marimón, José M ^a,b   Alonso, Marta ^b   Ercibengo, María ^b   García Arenzan, José M ^a  

^a BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CLONE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; OTITIS MEDIA; PENICILLIN RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EAR, MIDDLE; HUMANS; MICROBIAL SENSITIVITY TESTS; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84862513653     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00501-12     Document Type: Article

References (10)

1. Ardanuy C, et al. 2009. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J. Antimicrob. Chemother. 64:507-510.
2. Block SL, et al. 2004. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr. Infect. Dis. J. 23:829-833.
3. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI documentM100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Eskola J, et al. 2001. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344:403-409.
5. Fenoll A, et al. 2011. Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009. BMC Infect. Dis. 11:239. doi:10.1186/1471-2334-11-239.
6. Marimón JM, et al. 2012. Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994-2009). Eur. J. Clin. Microbiol. Infect. Dis. 31:1009-1013.
7. 14-5). Microb. Drug Resist. 9:133-137.
8. Marimón JM, Valiente A, Ercibengoa M, García-Arenzana JM, Pérez- Trallero E. 2005. Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae. Antimicrob. Agents Chemother. 49:5069-5074.
9. McEllistrem MC, et al. 2005. Acute otitis media due to penicillinnon-susceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin. Infect. Dis. 40:1738-1744.
10. Teele DW, Klein JO, Rosner B. 1989. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis. 160:83-94.